INS and diabetes mellitus: This review discusses the advantages of using nanocarriers (e.g., enhanced the solubility of poorly water-soluble sugar-lowering drugs, improved stability of insulin, increased absorption/permeation of loaded anti-diabetic drugs resulting in higher bioavailability) for the delivery of anti-diabetic drugs in the management of DM for different administration routes.